TREATMENT & INGREDIENTS

Why Eczema Always Comes Back When You Stop Treatment — and What Most Products Don't Fix

Published July 2026 Treatment & Ingredients ~4 min read

You put on the steroid cream. The eczema clears up. You stop. A few weeks later, it's back. You try the antihistamines. The itch settles. You run out. The itch returns. This cycle is exhausting — and it's not because your eczema is unusually stubborn. It's because almost every standard treatment is designed to manage the symptoms of eczema, not the underlying cause.

What's Actually Causing the Eczema

Eczema isn't just inflammation or an allergic response — at its root, it's a skin barrier disease. The outermost layer of your skin (the stratum corneum) acts like a protective wall, keeping moisture in and irritants out. In eczema-prone skin, that wall has structural gaps.

Specifically, eczema skin tends to be low in ceramides — lipid molecules that make up around 50% of the skin barrier's structure. It also often has reduced filaggrin, a protein that helps maintain the barrier's integrity and keeps skin hydrated and at the right pH. Without these, the barrier becomes too permeable: moisture escapes easily, and allergens, bacteria, and irritants get through.

This structural deficiency doesn't go away on its own. It's there before the flare, during the flare, and after treatment ends.

What Steroids and Antihistamines Actually Do

Steroid creams work by suppressing the inflammatory response — they quiet the cytokine signals that cause redness and itch. They work well for this. The problem is that once you stop, the barrier is in exactly the same condition it was before you started. The inflammation comes back because the entry point for triggers was never closed.

Antihistamines block itch signals, which is genuinely useful — especially for children who can't sleep. But histamine is a downstream part of the itch response. Blocking it doesn't affect the structural permeability of the barrier at all.

A 2020 study following over 4,000 eczema patients found that 65% had a relapse within 12 weeks of stopping steroid treatment. The treatments worked exactly as intended — the relapse happened because the barrier was never fixed.

Why Most Moisturisers Don't Solve the Problem Either

Standard moisturisers do useful work — they reduce dryness, improve comfort, and temporarily slow water loss. But they don't repair the barrier structurally. A standard emollient or lotion sits on the surface. When it wears off or gets washed away, the barrier is in the same condition it was before.

A 2019 study measured TEWL (transepidermal water loss) — the rate at which moisture escapes through the skin — before and after four weeks of emollient use. Research suggests that within 24 hours of stopping standard emollient use, TEWL can return close to pre-treatment levels — the barrier itself hadn't structurally changed.

There's an important distinction between moisturising (relieving dryness temporarily) and barrier repair (providing the building blocks the skin needs to rebuild its structure). These are not the same thing.

What Barrier Repair Actually Means

True barrier repair means delivering what the skin barrier is actually made of: ceramides, fatty acids, and cholesterol in proportions that match the skin's own lipid matrix. When these are delivered at the right concentrations, they can integrate into the stratum corneum and support structural improvement over weeks of consistent use.

REMDII Ultra Sensitive is formulated specifically around this approach — ceramides at the physiological 3:1:1 ratio (ceramide:cholesterol:fatty acid), alongside Full-Spectrum Vitamin E (Tocotrienol, Tocopherol, Beta-carotene) from Malaysian palm oil. Tocotrienols support membrane integrity and help reduce oxidative stress at the cell level, contributing to barrier recovery beyond ceramide delivery alone.

Barrier repair isn't a quick fix — it works over weeks, not days. But it's the approach that addresses what treatments like steroids leave untouched.

Frequently asked questions

If eczema is genetic, can the barrier actually be improved?
Yes. Genetic mutations (like FLG mutations affecting filaggrin) reduce barrier function — but they don't eliminate other repair pathways. Ceramide synthesis, tight junction maintenance, and lipid organisation can all still be improved through consistent barrier-focused care, even with a genetic predisposition. Many people with confirmed mutations achieve long-term remission.
Are newer treatments like dupilumab (Dupixent) barrier repair?
Dupilumab targets the inflammatory signals that damage the barrier, and some indirect barrier improvements follow as inflammation reduces. But it doesn't directly rebuild ceramides or restore filaggrin. It addresses an upstream driver, which helps — but it's not a structural barrier repair in the direct sense.
Why don't more doctors talk about barrier repair?
Conventional treatment guidelines focus on measurable short-term outcomes — symptom scores at 12–16 weeks. Anti-inflammatory treatments produce clear, fast results. Barrier repair is slower and less dramatic. Most dermatologists do recommend emollients — but the clinical emphasis has historically been on the anti-inflammatory side because that's where the trial data clusters.
R

REMDII

Sensitive skin science, by LIPIDGROUP

REMDII develops barrier-repair skincare grounded in lipid science and formulated for sensitive, eczema-prone skin in Malaysia’s climate. Our articles translate published dermatological research into practical, everyday guidance.

Available at 1,000+
clinics and pharmacies in
Malaysia and Singapore.

Recommended by healthcare professionals
who see the results firsthand.

Shop Now